• Home
  • Textbooks
  • Abrams' clinical drug therapy : rationales for nursing practice
  • Drug Therapy for Dyslipidemia

Abrams' clinical drug therapy : rationales for nursing practice

Geralyn Frandsen; Sandra Smith Pennington; Anne Collins Abrams

Chapter 8

Drug Therapy for Dyslipidemia - all with Video Answers

Educators


Chapter Questions

01:34

Problem 1

Jason Smith is recently seen in college health services with the following lipid profile: total serum cholesterol $278 \mathrm{mg} / \mathrm{dL}$, LDL cholesterol $210 \mathrm{mg} / \mathrm{dL}$, HDL cholesterol $38 \mathrm{mg} / \mathrm{dL}$, and triglycerides $150 \mathrm{mg} / \mathrm{dL}$.
- What are the main nonpharmacologic measures to decrease total and LDL cholesterol and serum triglycerides and increase HDL cholesterol?
- What is the goal of management of dyslipidemia?

Gavin Liang
Gavin Liang
Numerade Educator